by Maria Zannes | Sep 10, 2021 | Events
bioAffinity Technologies President and CEO Maria Zannes will present the Company’s recent advancements in commercializing CyPath® Lung, a noninvasive test to diagnose early stage lung cancer and meet with investors at H.C. Wainwright & Company’s 23rd Annual Global...
by Maria Zannes | Aug 12, 2021 | Press Releases
AUGUST 12, 2021 (SAN ANTONIO, TX) bioAffinity Technologies, a privately held company focused on early diagnostics and cancer therapeutics, announced publication in the peer-reviewed Journal of Visualized Experiments (JoVE). The paper, entitled Quality-Controlled...
by Maria Zannes | Jun 23, 2021 | Events, Press Releases
JUNE 23, 2021 (SAN ANTONIO, TX) bioAffinity Technologies, a privately held biotech company, will present the Company’s discoveries in the field of cancer diagnostics and therapeutics at the RNA Therapeutics Institute’s 2021 RNA Therapeutics Symposium June 23 – 25,...
by Maria Zannes | Jun 8, 2021 | Events
Dr. Elzi will present his poster “Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” at the University of Massachusetts RNA Therapeutics Symposium: From Concept to Clinic, June 23-25, 2021. Dr. Elzi’s live presentation will...
by Maria Zannes | Mar 20, 2021 | Articles, News
Local CEO: New recommendations acknowledge that women and Black people are at higher risk than white men MARCH 19, 2021 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San-Antonio Business Journal Several major national medical...
